(Total Views: 541)
Posted On: 08/08/2021 9:44:39 PM
Post# of 153880
Has Northwestern always been a part of the triple negative breast cancer trial?
This came up when I was searching this evening and they are not listed under the study at clinicaltrials.gov or are they the investigational site in Illinois?
Would be nice to see the trial expand to other academic centers.
https://www.medicine.northwestern.edu/researc...ology.html
The following searchable list includes all the Division of Hematology-Oncology - Department of Medicine clinical trials currently looking for participants.
-> scroll through to reach:
DRUG CD07_TNBC: A Phase Ib/II Study of Leronlimab (PRO 140) Combined with Carboplatin in Patients with CCR5+ Metastatic Triple-Negative Breast Cancer (mTNBC)
The purpose of this study to find out if the study drug, leronlimab (PRO 140), when given incombination with another chemotherapy drug, carbopl…
This came up when I was searching this evening and they are not listed under the study at clinicaltrials.gov or are they the investigational site in Illinois?
Would be nice to see the trial expand to other academic centers.
https://www.medicine.northwestern.edu/researc...ology.html
The following searchable list includes all the Division of Hematology-Oncology - Department of Medicine clinical trials currently looking for participants.
-> scroll through to reach:
DRUG CD07_TNBC: A Phase Ib/II Study of Leronlimab (PRO 140) Combined with Carboplatin in Patients with CCR5+ Metastatic Triple-Negative Breast Cancer (mTNBC)
The purpose of this study to find out if the study drug, leronlimab (PRO 140), when given incombination with another chemotherapy drug, carbopl…
(7)
(0)
